WARF Ventures

What WARF Ventures does

WARF Ventures is the startup investment and support program of the Wisconsin Alumni Research Foundation (WARF), an independent nonprofit foundation founded in 1925 to steward the cycle of research, discovery, commercialization, and investment for the University of Wisconsin-Madison. WARF Ventures specifically provides seed and growth capital, mentorship, and portfolio support to early-stage companies formed around UW-Madison research, complementing the foundation's parallel programs — WARF Accelerator (mentorship and milestone-based funding for emerging technologies), WARF Therapeutics (pharmaceutical and biotech partnerships), UpStart, and Third Coast Foundry (startup initiatives).

The foundation operates a technology transfer platform built on an Intellectual Property Disclosure System and a Patent Portfolio Management operation covering more than 2,200 active issued U.S. patents and 630 active commercial licenses across life sciences, physical sciences, clean tech, computer science and engineering, food and agriculture, and research tools. Researchers submit invention disclosures through a secure portal; WARF then prosecutes patents, markets technologies to industry, negotiates licensing agreements, and routes commercially promising technologies into its accelerator, therapeutics, and ventures funnels. Co-funded Challenge Grants with Bayer Crop Science, Zoetis, MilliporeSigma, Nexus NeuroTech Ventures, and Route 66 Ventures channel corporate R&D demand into specific verticals.

WARF generates revenue primarily through patent licensing royalties, investment portfolio returns, and a newly formalized Data Licensing program that monetizes UW-Madison research data sets for academic and commercial AI/ML applications. The foundation has distributed over $4.6 billion in cumulative grants to UW-Madison and the Morgridge Institute for Research since inception, committed $206.9 million at its centennial, and serves UW-Madison researchers, corporate licensees, and portfolio startups as its three primary customer segments. Distribution is direct and field-led, with headquarters at 614 Walnut Street, Madison, Wisconsin.

Name

WARF Ventures

Legal name

Wisconsin Alumni Research Foundation

Website

https://warf.org

Company type

Private

Founded year

1925

Operating status

Operating

Headcount range

1–10 employees

Short description

WARF Ventures is the startup investment arm of the Wisconsin Alumni Research Foundation, providing seed and growth funding, mentorship, and portfolio support to early-stage startups commercializing University of Wisconsin-Madison research across life sciences, clean tech, and engineering.

Ownership category

akta.pro rank

Product category

Technology Transfer and Research Commercialization

NAICS

Portfolio Management and Investment Advice (52394)

SIC

Patent Owners & Lessors (6794)

akta.pro primary industry

Early-Stage Venture Capital (Series A/B) (FSANAAAB)

akta.pro secondary industries

Early-Stage Venture Capital (Pre-Seed/Seed) (FSANAAAA), Education & Workforce Development Impact Funds (FSANAJAJ)

Keywords

• Technology transfer services
• Patent licensing
• University research commercialization
• Venture capital funding
• Startup incubation

Headquarters

HQ city

Madison

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Patent Licensing: WARF manages patents for UW-Madison discoveries and licenses inventions to industry, generating revenue from licensing fees and royalties.
2. Investment Returns: WARF maintains an investment portfolio that supports university research and generates returns.
3. Data Licensing: Licensing of research data sets generated by UW-Madison to academic researchers and commercial partners.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

WARF Ventures provides seed and growth funding to early-stage startups commercializing University of Wisconsin-Madison research, operating as part of the Wisconsin Alumni Research Foundation (WARF). It supports UW-Madison technology startups through investment opportunities, portfolio management, mentorship from industry experts, and connections to industry partners, while also managing intellectual property protection, patenting services, technology licensing to established companies, and data licensing programs.

Product overview

WARF Ventures is not a standalone product company but rather a technology transfer and commercialization organization that operates as part of the Wisconsin Alumni Research Foundation (WARF). As a university technology transfer office established in 1925, WARF manages patents, licenses inventions to industry, and funds UW-Madison research through various programs. The core offerings include the WARF Accelerator (mentoring and funding for emerging technologies), WARF Therapeutics (pharma/biotech partnerships), WARF Ventures (startup resources), Data Licensing services, Innovation Disclosure processing, and Challenge Grants co-funded with industry partners. The organization stewards the cycle of research, discovery, commercialization, and investment for the University of Wisconsin-Madison, supporting over 2,200 active issued U.S. patents and $4.6 billion in cumulative grants.

Differentiator

Problem solved

Functional benefit

Brands

• WARF Accelerator: Expert industry advice and funding for commercially promising emerging technologies from UW-Madison.
• WARF Therapeutics
• WARF Ventures
• UpStart

Products and services

• WARF Accelerator Expert industry advice and targeted funding for commercially promising emerging technologies from UW-Madison, helping de-risk technologies and advance them closer to the marketplace through Catalysts (Fortune 500 mentors) and milestone-based financial support across five industry lanes.
• WARF Therapeutics WARF's pharmaceutical and biotech partnership program that serves as the connection between UW-Madison researchers and industry partners for drug discovery and translational medicine.
• WARF Ventures Resources to help UW-Madison technology startups succeed, including investment opportunities and portfolio support for early-stage companies commercializing UW-Madison discoveries.
• Data Licensing Program to maximize the impact of UW-Madison research data by facilitating access for academic researchers and commercial partners, enabling licensing arrangements that offset data collection costs and enhance AI/ML training opportunities.
• Innovation Disclosure The first step in WARF's proven technology patenting process where inventors submit innovation disclosures to protect their intellectual property before public disclosure.
• Challenge Grants Targeted grant programs co-funded with industry partners to advance research in specific domains including non-animal testing, plant sciences, animal health, neurotechnology, and cardiology.
• UpStart Startup support program within WARF's portfolio helping entrepreneurs launch companies based on UW-Madison technologies.
• Third Coast Foundry Startup initiative within the WARF Ventures portfolio supporting UW-Madison technology ventures.

Quantifiable outcome

• Over $4.6 billion in cumulative grants to UW-Madison and Morgridge Institute
• +1 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Bayer Crop SciencecoreStrategic or Co-development PartnerWARF and Bayer Crop Science have partnered on innovation challenges focused on novel solutions to create resilient and secure food systems. The partnership includes the WARF/Bayer Challenge Grant: Plant Sciences, with WARF Accelerator awarding 2-5 grants from a $100K pool for research in crop production improvement.
• ZoetiscoreStrategic or Co-development PartnerWARF and Zoetis, the global leader in animal health, have teamed together to launch the WARF Accelerator & Zoetis Animal Health Challenge Grant. WARF Accelerator awards 5-10 early-stage projects from a pool of $200,000 co-funded by WARF and Zoetis for technologies impacting animal health research.
• Nexus NeuroTech VenturescoreStrategic or Co-development PartnerWARF and Nexus NeuroTech Ventures partnered to launch the Neurotechnology Challenge Grant, awarding 2-5 grants from approximately $100,000 for breakthrough technologies for brain disorders including medical devices, software, diagnostics, and research tools.
• Route 66 VenturesminorStrategic or Co-development PartnerWARF Accelerator & Route 66 Ventures Cardiology Challenge Grant, with WARF Accelerator awarding 2-5 grants from a $100K pool for cardiovascular technologies.
• MilliporeSigmacoreStrategic or Co-development PartnerWARF Accelerator & MilliporeSigma Non-Animal Testing Challenge Grant, awarding 5-10 grants from a $200K pool to advance non-animal testing technologies.
• Morgridge Institute for ResearchcoreStrategic or Co-development PartnerWARF provides annual grants and supports the cycle of research, discovery, and commercialization in partnership with the Morgridge Institute for Research, which is co-located with UW-Madison.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Osage University Partners: Specialized venture firm that invests exclusively in university-licensed spinouts. Directly comparable to WARF Ventures as both target the same university IP commercialization channel and provide capital to technology startups originating from academic research.
• University of Michigan Innovation Partnerships: Handles technology transfer and startup support for University of Michigan research. Comparable as a major public-university TTO with similar program structure (licensing, accelerator, startup formation).
• Harvard Office of Technology Development (OTD): Harvard's central TTO managing licensing, material transfer agreements, and startup formation from Harvard research. Directly comparable in mandate, scale of patent estate, and exclusive university relationship.
• Columbia Technology Ventures: Columbia University's TTO responsible for evaluating, patenting, and licensing inventions from Columbia researchers. Comparable in structure and scope as a single-university technology commercialization organization.
• Stanford Office of Technology Licensing (OTL): Stanford's designated TTO managing patent licensing and startup formation from Stanford research. Comparable to WARF in operating model, scope (large patent portfolio + startup support), and relationship with a single anchor research university.
• MIT Technology Licensing Office: MIT's TTO handles IP protection, licensing, and startup formation from MIT research. Directly comparable to WARF in function, scale of patent portfolio, and dedicated accelerator (MIT Sandbox / MIT Founders) for spinout support.

Broad incumbents

• Allied Minds: Public holding company that forms, funds, and operates startups based on university-licensed IP. Comparable to WARF Ventures in targeting university spinouts, but operates as a for-profit commercial enterprise with a broader multi-university sourcing model.
• Intellectual Ventures (now Invention Science Fund / IXC): Large patent aggregation and licensing firm. Comparable to WARF's patent licensing function at a much larger scale, though operates as a commercial IP holding entity rather than a university TTO.
• Battelle Memorial Institute: Large nonprofit that manages and commercializes IP from government and academic research. Comparable to WARF in nonprofit structure and IP commercialization mission, but at significantly larger scale and with broader R&D management scope.

Others

• Tech Transfer Central / Association of University Technology Managers (AUTM): Industry association and resource hub for university technology transfer offices. Comparable ecosystem context for WARF as a peer network of TTO professionals and best-practice sharing for university IP commercialization.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/WARF_News
• YouTubeyoutube.com/channel/UCgM5zUQeM0aFkxgxHIwgG9Q
• Facebookfacebook.com/WisconsinAlumniResearchFoundation
• LinkedInlinkedin.com/company/wisconsin-alumni-research-foundation

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments13 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WARF Ventures